16/10/2014 Two VHIR platforms become facilities of the Spanish Map of Singular Scientific and Technical Infrastructures 16/10/2014 The Molecular Imaging Platform and the Area of Functional Validation and Preclinical Research are part of the CIBER-BBN The council of Political Science, Technology and Innovation approved the new so-called Spanish Map of Singular and Technical Infrastructures (ICTS) that, for the first time, includes two platforms of the Vall d’Hebron Institute of Research (VHIR). These platforms are the "http://www.vhir.org/fvpr/presentacioserveis.asp?Idioma=en&mv1=6&mv2=1&mh1=6&mh2=1&mh3=1&mh4=0&ms=0&m_es=6" Area of Functional Validation and Preclinical Research (FVPR), managed by the CIBBIM-Nanomedicine, and the "http://www.vhir.org/serveis/estabulari/plataforma_imatge_molecular.asp?Idioma=en&mv1=3&mv2=3&mh1=3&mh2=3&mh3=4&mh4=1&ms=0" Molecular Imaging Platform, located in the Animal Facilities of the Institute. Both infrastructures are integrated in the Spanish network of biomedical research in bioengineering, biomaterials and nanomedicine (CIBER-BBN).The FVPR aims to provide the industry and other research groups with an optimum technical platform for testing new biomedical applications based on the nanotechnology from compounds for the treatment of specific diseases to new applications in diagnosis and imaging.One of the services of the FVPR is the Molecular Imaging Platform, established through the common efforts of CIBER-BBN, CIBBIM-Nanomedicina and VHIR, as a service to research groups and pharmaceutical companies. Its mission consists in provide the capacity to develop noninvasive optical image in vivo at cellular, molecular and functional level, including fluorescence and bioluminescence.Both services are part, together with 27 Spanish infrastructures, of the NANBIOSIS platform, which is devoted to produce and characterize nanomaterials, biomaterials and biomedical systems at the CIBER-BBN. This platform is oriented towards medical applications and aims to give an easy full service to researchers. It includes the design, production of biomaterials and nanomaterials, the characterization of these materials and tissues, and the development of medical devices and systems from a physical, chemical, functional, toxicological and biological point of view, including the preclinical validation (which is the part carried out at VHIR).The "http://www.idi.mineco.gob.es/portal/site/MICINN/menuitem.6f2062042f6a5bc43b3f6810d14041a0/?vgnextoid=2693ce5451f44410VgnVCM1000001d04140aRCRD" new map approved by the government has 29 ICTS that include a total of 59 infrastructures. All of them passed a rigorous assessment process and demonstrated their economic sustainability. Twitter LinkedIn Facebook Whatsapp